Your browser doesn't support javascript.
loading
Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases.
Kay, Jonathan; Schoels, Monika M; Dörner, Thomas; Emery, Paul; Kvien, Tore K; Smolen, Josef S; Breedveld, Ferdinand C.
Afiliación
  • Kay J; Division of Rheumatology, Department of Medicine, UMass Memorial Medical Center and University of Massachusetts Medical School, Worcester, Massachusetts, USA.
  • Schoels MM; Department of Internal Medicine, Centre for Rheumatic Diseases, Hietzing Hospital, Vienna, Austria.
  • Dörner T; Department of Medicine/Rheumatology and Clinical Immunology, Charité Universitätsmedizin and Deutsches Rheumaforschungszentrum (DRFZ), Berlin, Germany.
  • Emery P; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK.
  • Kvien TK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
  • Smolen JS; Department of Internal Medicine, Centre for Rheumatic Diseases, Hietzing Hospital, Vienna, Austria.
  • Breedveld FC; Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria.
Ann Rheum Dis ; 77(2): 165-174, 2018 02.
Article en En | MEDLINE | ID: mdl-28866648

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Reumáticas / Biosimilares Farmacéuticos Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Reumáticas / Biosimilares Farmacéuticos Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos